|Articles|January 1, 2017
January 2017: Setting the Pace for the Patient Journey
Author(s)Triplefin
How Triplefin’s suite of hub-based e-solutions and customized investments in the “human touch” are outrunning the clock on prior authorization claims-a key source of delays in patient speed to therapy.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Unpacking IRA-Driven Formulary Pressure
2
President Trump Set to Nominate Heidi Overton as FDA Commissioner
3
When Drug Pricing Becomes Trade Policy
4
From Pilot to Profit: How Pharma Leaders Are Scaling AI Across the Drug Lifecycle
5
